Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000669731 | SCV000794510 | uncertain significance | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2017-09-27 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV001074211 | SCV001239784 | uncertain significance | Retinal dystrophy | 2019-04-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001244688 | SCV001417926 | pathogenic | not provided | 2024-12-07 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 4447 of the USH2A protein (p.Met4447Val). This variant is present in population databases (rs139474806, gnomAD 0.08%). This missense change has been observed in individual(s) with USH2A-related conditions (PMID: 29625443, 31872526, 31960602; internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 554155). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt USH2A protein function with a negative predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Ocular Genomics Institute, |
RCV001376262 | SCV001573341 | uncertain significance | Retinitis pigmentosa 39 | 2021-04-08 | criteria provided, single submitter | research | The USH2A c.13339A>G variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PM2. Based on this evidence we have classified this variant as Variant of Uncertain Significance. |
Gene |
RCV001244688 | SCV001774020 | uncertain significance | not provided | 2024-07-24 | criteria provided, single submitter | clinical testing | Observed with a pathogenic or likely pathogenic variant on the same allele (in cis) in an individual referred for genetic testing at GeneDx; In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 35456422, 31054281, 24938718, 20507924, 23661368, 31960602, 31456290, 33608557, 31964843, 36729443, 36819107, 34906470, 34721897, 33124170, 31872526, 33090715, 33946315, 32675063, 32188678, 38879497, 29625443) |
Broad Center for Mendelian Genomics, |
RCV001003255 | SCV001950421 | uncertain significance | Retinitis pigmentosa | 2021-04-01 | criteria provided, single submitter | curation | The p.Met4447Val variant in USH2A was identified in an individual with Retinitis pigmentosa, via a collaborative study between the Broad Institute's Center for Mendelian Genomics and the Pierce lab (https://oculargenomics.meei.harvard.edu/labs/pierce-lab/lab-members/). Through a review of available evidence we were able to apply the following criteria: PM2. Based on this evidence we have classified this variant as a Variant of Uncertain Significance. If you have any questions about the classification please reach out to the Pierce Lab. |
3billion, |
RCV003313971 | SCV004013500 | uncertain significance | Usher syndrome type 2A | criteria provided, single submitter | clinical testing | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.012%). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with USH2A related disorder (3billion dataset). However, the evidence of pathogenicity is insufficient at this time. A different missense change at the same codon (p.Met4447Leu) has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000930727). Therefore, this variant is classified as Uncertain significance according to the recommendation of ACMG/AMP guideline. | |
Baylor Genetics | RCV001376262 | SCV004208156 | likely pathogenic | Retinitis pigmentosa 39 | 2024-03-30 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV001074211 | SCV004707245 | likely pathogenic | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Fulgent Genetics, |
RCV000669731 | SCV005645460 | likely pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2024-03-05 | criteria provided, single submitter | clinical testing | |
Sharon lab, |
RCV001003255 | SCV001161336 | likely pathogenic | Retinitis pigmentosa | 2019-06-23 | no assertion criteria provided | research |